Mechanisms of Reduced Susceptibility to Ciprofloxacin inEscherichia coliIsolates from Canadian Hospitals

Author:

Baudry-Simner Patricia J12,Singh Amanpreet1,Karlowsky James A12,Hoban Daryl J12,Zhanel George G12,Canadian Antimicrobial Resistance Alliance

Affiliation:

1. Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Canada

2. Department of Clinical Microbiology, Health Sciences Centre, Winnipeg, Manitoba, Canada

Abstract

OBJECTIVE: To determine whether plasmid-mediated quinolone resistance (PMQR) determinants play a role in the increasing resistance to fluoroquinolones amongEscherichia coliisolates in Canadian hospitals, and to determine the mechanisms of reduced susceptibility to ciprofloxacin in a recent collection of 190 clinicalE coliisolates.METHODS:E coliisolates (n=1702) were collected as part of the 2007 Canadian Hospital Ward Antibiotic Resistance Surveillance (CANWARD) study. Antimicrobial susceptibility testing was performed by Clinical and Laboratory Standards Institute (CLSI) broth microdilution. Using a representative subset of isolates (n=190), the mechanisms of reduced susceptibility to ciprofloxacin were detected by polymerase chain reaction and sequencing of the quinolone resistance-determining regions (QRDR) of chromosomalgyrAandparCgenes, and by polymerase chain reaction for the PMQR genes:qnr,aac(6) Ib-crandqepA.RESULTS: 2.1% and 1.1% ofE coliharbouredaac(6)Ib-crandqnrB, respectively. Single amino acid substitutions in the QRDR ofgyrAwere observed among isolates with ciprofloxacin minimum inhibitory concentrations as low as 0.12 μg/mL. As the ciprofloxacin minimum inhibitory concentration increased to 1 μg/mL (which is still considered to be susceptible by the CLSI), the vast majority of isolates demonstrated bothgyrAandparCmutations.CONCLUSION: PMQR determinants and QRDR mutants among clinicalE coliisolates with reduced susceptibility to ciprofloxacin demonstrates the need for increased surveillance and the need to re-evaluate the current CLSI breakpoints to prevent further development of fluoroquinolone resistance.

Publisher

Hindawi Limited

Subject

Infectious Diseases,Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3